Charles K. Dargan - Aug 13, 2024 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Financial Officer
Signature
/s/ John R. Browning, attorney-in-fact
Stock symbol
BLGO
Transactions as of
Aug 13, 2024
Transactions value $
$0
Form type
4
Date filed
8/15/2024, 03:13 PM
Previous filing
Jun 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option Award $0 +300K +6.94% $0.00 4.63M Aug 13, 2024 common stock 300K $0.24 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option vests in equal monthly installments of 25,000 shares, so long as the Engagement Extension Agreement dated August 13, 2024, between Reporting Person and Issuer, remains in force and effect.
F2 This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from February 1, 2024, through January 31, 2025.